Harari P M PM - OmicsDI

Previous page
1 / 3
You're on page 1
page 2
page 3
Next page

Sort by:

Relevance

Page size

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

Not available

S-EPMC4121506 | biostudies-literature

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.

Not available

S-EPMC4251957 | biostudies-literature

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Not available

S-EPMC3216115 | biostudies-literature

Regulation of HB-EGF by miR-212 and acquired cetuximab-resistance in head and neck cancer

To determine the mechanism of cetuximab-resistance in head and neck cancer, a cetuximab-sensitive cell line (SCC1) and its cetuximab-resistant derivative (1Cc8) were analyzed for differentially expressed genes using DNA microarrays. 900 differentially expressed genes were found using the statistical...

ORGANISM(S): Homo sapiens

2011-01-14 | E-GEOD-21483 | biostudies-arrayexpress

Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Not available

S-EPMC7069668 | biostudies-literature

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Not available

S-EPMC3525135 | biostudies-literature

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).

Not available

S-EPMC5086582 | biostudies-literature

Morphologic Spectrum of HPV-associated Sinonasal Carcinomas.